Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
2(50%)

Phase Distribution

Ph phase_4
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

completed250%
terminated250%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_4

Thyroid Function of Pediatric Subjects Following Isovue® Administration

NCT03779906
terminated

PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease

NCT05031520
completedphase_4

Thoracoabdominal Arortic CTA Study

NCT02291718
completedphase_4

Detection of Pulmonary Embolism With CECT

NCT00351754

Clinical Trials (4)

Showing 4 of 4 trials
NCT03779906Phase 4

Thyroid Function of Pediatric Subjects Following Isovue® Administration

Terminated
NCT05031520

PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease

Terminated
NCT02291718Phase 4

Thoracoabdominal Arortic CTA Study

Completed
NCT00351754Phase 4

Detection of Pulmonary Embolism With CECT

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4